Flexion Therapeutics, Inc. – NASDAQ:FLXN
Flexion Therapeutics stock price today
$25.285
+16.16
+177.25%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 9 hours
Flexion Therapeutics stock price quarterly change
-0.76%
quarter
Flexion Therapeutics stock price yearly change
-24.57%
year
Flexion Therapeutics key metrics
Market Cap | N/A |
Enterprise value | 579.04M |
P/E | -4.55 |
EV/Sales | 5.76 |
EV/EBITDA | -7.65 |
Price/Sales | 4.56 |
Price/Book | -5.56 |
PEG ratio | -0.12 |
EPS | -2.07 |
Revenue | 100.4M |
EBITDA | -75.67M |
Income | -100.72M |
Revenue Q/Q | -9.87% |
Revenue Y/Y | 21.11% |
Profit margin | -100.32% |
Oper. margin | -78.17% |
Gross margin | 78.93% |
EBIT margin | -78.17% |
EBITDA margin | -75.38% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeFlexion Therapeutics stock price history
Flexion Therapeutics stock forecast
Flexion Therapeutics financial statements
| Dec 2020 | 26.31M | -19.64M | -74.68% |
|---|---|---|---|
| Mar 2021 | 24.58M | -28.55M | -116.13% |
| Jun 2021 | 28.17M | -22.20M | -78.82% |
| Sep 2021 | 21.32M | -30.31M | -142.14% |
| 2021-03-10 | -0.46 | -0.4 |
|---|---|---|
| 2021-05-12 | -0.52 | -0.57 |
| 2021-08-04 | -0.5 | -0.44 |
| 2021-11-12 | -0.56 | -0.6 |
| Dec 2020 | 251926000 | 268.58M | 106.61% |
|---|---|---|---|
| Mar 2021 | 230379000 | 269.24M | 116.87% |
| Jun 2021 | 210047000 | 266.21M | 126.74% |
| Sep 2021 | 217931000 | 300.30M | 137.8% |
| Dec 2020 | -9.74M | -12.09M | 907K |
|---|---|---|---|
| Mar 2021 | -18.47M | 10.94M | -1.47M |
| Jun 2021 | -18.76M | 31.34M | -3.66M |
| Sep 2021 | -14.20M | 17.93M | 25.46M |
Flexion Therapeutics alternative data
| Aug 2023 | 257 |
|---|---|
| Sep 2023 | 257 |
| Oct 2023 | 257 |
| Nov 2023 | 257 |
| Dec 2023 | 257 |
| Jan 2024 | 257 |
| Feb 2024 | 257 |
| Mar 2024 | 257 |
| Apr 2024 | 257 |
| May 2024 | 257 |
| Jun 2024 | 257 |
| Jul 2024 | 257 |
Flexion Therapeutics other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2021 | 0 | 39791 |
| Mar 2021 | 0 | 4520 |
| May 2021 | 0 | 2229 |
| Jul 2021 | 0 | 13704 |
| Patent |
|---|
Application Filling date: 16 Mar 2018 Issue date: 9 Jan 2020 |
| Quarter | Transcript |
|---|---|
| Q2 2021 4 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 12 May 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 10 Mar 2021 | Q4 2020 Earnings Call Transcript |
| Q1 2020 8 May 2020 | Q1 2020 Earnings Call Transcript |
-
What's the price of Flexion Therapeutics stock today?
One share of Flexion Therapeutics stock can currently be purchased for approximately $25.29.
-
When is Flexion Therapeutics's next earnings date?
Unfortunately, Flexion Therapeutics's (FLXN) next earnings date is currently unknown.
-
Does Flexion Therapeutics pay dividends?
No, Flexion Therapeutics does not pay dividends.
-
What is Flexion Therapeutics's stock symbol?
Flexion Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "FLXN".
-
What is Flexion Therapeutics's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Flexion Therapeutics?
Shares of Flexion Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Flexion Therapeutics have?
As Jul 2024, Flexion Therapeutics employs 257 workers.
-
When Flexion Therapeutics went public?
Flexion Therapeutics, Inc. is publicly traded company for more then 11 years since IPO on 12 Feb 2014.
-
What is Flexion Therapeutics's official website?
The official website for Flexion Therapeutics is flexiontherapeutics.com.
-
Where are Flexion Therapeutics's headquarters?
Flexion Therapeutics is headquartered at 10 Mall Rd Ste 301, Burlington, MASSACHUSETTS.
-
How can i contact Flexion Therapeutics?
Flexion Therapeutics's mailing address is 10 Mall Rd Ste 301, Burlington, MASSACHUSETTS and company can be reached via phone at +1 781 305 7777.
Flexion Therapeutics company profile:
Flexion Therapeutics, Inc.
flexiontherapeutics.comExchange:
NASDAQ
Full time employees:
257
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201, a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, an administered NaV1.7 inhibitor for the management of post-operative pain. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
10 Mall Rd Ste 301
Burlington, MASSACHUSETTS 01803
Burlington, MASSACHUSETTS 01803
CIK: 0001419600
ISIN: US33938J1060
CUSIP: 33938J106
